Cargando…

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

AIMS/HYPOTHESIS: Metformin is the most-prescribed oral medication to lower blood glucose worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in reducing risk of cardiovascular disease, the most costly complication of type 2 diabetes. We aimed to systematically ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffin, Simon J., Leaver, James K., Irving, Greg J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552849/ https://www.ncbi.nlm.nih.gov/pubmed/28770324 http://dx.doi.org/10.1007/s00125-017-4337-9

Ejemplares similares

Metformin Protects Cardiovascular Health in People With Diabetes
por: Chen, Chong, et al.
Publicado: (2022)

Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
por: Boussageon, Rémy, et al.
Publicado: (2012)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
Publicado: (2010)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
por: De Berardis, Giorgia, et al.
Publicado: (2009)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
por: Gebrie, Desye, et al.
Publicado: (2021)

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
por: Currie, Craig J., et al.
Publicado: (2012)

Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial
por: Black, James A, et al.
Publicado: (2014)

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
por: Brugts, J J, et al.
Publicado: (2009)

Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
por: Wang, Jingya, et al.
Publicado: (2021)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
por: Wilding, J P H, et al.
Publicado: (2013)

Effects of metformin and alogliptin on body composition in people with type 2 diabetes
por: Takeshita, Yumie, et al.
Publicado: (2018)

Fruit and vegetable intake and cardiovascular risk factors in people with newly diagnosed type 2 diabetes
por: Lamb, M J E, et al.
Publicado: (2017)

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
por: Lavalle-González, F. J., et al.
Publicado: (2013)

Patterns of metformin monotherapy discontinuation and reinitiation in people with type 2 diabetes mellitus in New Zealand
por: Horsburgh, Simon, et al.
Publicado: (2021)

Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study
por: Wood, Stephen, et al.
Publicado: (2021)

Psychometric and biomedical outcomes of glycated haemoglobin target-setting in adults with type 1 and type 2 diabetes: Protocol for a mixed-methods parallel-group randomised feasibility study
por: Westall, Samuel J., et al.
Publicado: (2022)

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening
por: Webb, DR, et al.
Publicado: (2010)

Patients’ views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years
por: Dambha-Miller, Hajira, et al.
Publicado: (2018)

The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial
por: Wild, Sarah, et al.
Publicado: (2013)

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
por: Strelitz, Jean, et al.
Publicado: (2019)

Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
por: Golledge, Jonathan, et al.
Publicado: (2021)

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
por: de Jager, Jolien, et al.
Publicado: (2010)

Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
por: Wen, Jie, et al.
Publicado: (2022)

Patient-centred care, health behaviours and cardiovascular risk factor levels in people with recently diagnosed type 2 diabetes: 5-year follow-up of the ADDITION-Plus trial cohort
por: Dambha-Miller, Hajira, et al.
Publicado: (2016)

Effect on cardiovascular disease risk factors of interventions to alter consultations between practitioners and patients with type 2 diabetes: A systematic review and meta‐analysis of trials in primary care
por: Dambha‐Miller, Hajira, et al.
Publicado: (2017)

Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
por: Griffin, Simon J, et al.
Publicado: (2011)

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
por: Behzad, Molavi, et al.
Publicado: (2007)

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
por: Bailey, Clifford J, et al.
Publicado: (2013)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Cardiovascular risk assessment scores for people with diabetes: a systematic review
por: Chamnan, P., et al.
Publicado: (2009)

Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial
por: Marteau, Theresa M, et al.
Publicado: (2010)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2022)

Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
por: Zhu, Hongmei, et al.
Publicado: (2013)

The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Liu, Wei, et al.
Publicado: (2016)

Effect of Metformin on Lipid Profiles of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
por: Gillani, Syed Wasif, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a07ftknqo6bjl39n938epm43aq